These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

766 related items for PubMed ID: 18656249

  • 1. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor.
    Kang H, Kim TJ, Kim WY, Choi CH, Lee JW, Kim BG, Bae DS.
    Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249
    [Abstract] [Full Text] [Related]

  • 2. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour.
    Satoh T, Aoki Y, Kasamatsu T, Ochiai K, Takano M, Watanabe Y, Kikkawa F, Takeshima N, Hatae M, Yokota H, Saito T, Yaegashi N, Kobayashi H, Baba T, Kodama S, Saito T, Sakuragi N, Sumi T, Kamura T, Yoshikawa H.
    Eur J Cancer; 2015 Feb; 51(3):340-51. PubMed ID: 25559616
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of 129 patients with advanced and recurrent malignant ovarian germ cell tumor].
    Hong W, Zhang R, Liu L.
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):35-7. PubMed ID: 10682456
    [Abstract] [Full Text] [Related]

  • 4. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
    Li J, Yang W, Wu X.
    Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
    [Abstract] [Full Text] [Related]

  • 5. Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor.
    de La Motte Rouge T, Pautier P, Duvillard P, Rey A, Morice P, Haie-Meder C, Kerbrat P, Culine S, Troalen F, Lhommé C.
    Ann Oncol; 2008 Aug; 19(8):1435-1441. PubMed ID: 18408223
    [Abstract] [Full Text] [Related]

  • 6. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
    Cicin I, Saip P, Guney N, Eralp Y, Ayan I, Kebudi R, Topuz E.
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810
    [Abstract] [Full Text] [Related]

  • 7. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF, Yang QY, Zhen ZJ, Xia Y, Huang ZH, Ling JY.
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [Abstract] [Full Text] [Related]

  • 8. Conservative treatment and long-term follow up of endodermal sinus tumor of the vagina.
    Tao T, Yang J, Cao D, Guo L, Chen J, Lang J, Shen K.
    Gynecol Oncol; 2012 May; 125(2):358-61. PubMed ID: 22178761
    [Abstract] [Full Text] [Related]

  • 9. Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study.
    Dimopoulos MA, Papadimitriou C, Hamilos G, Efstathiou E, Vlahos G, Rodolakis A, Aravantinos G, Kalofonos H, Kouroussis C, Gika D, Skarlos D, Bamias A.
    Gynecol Oncol; 2004 Dec; 95(3):695-700. PubMed ID: 15581984
    [Abstract] [Full Text] [Related]

  • 10. Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant ovarian germ cell tumors: report of 2 cases.
    Han JY, Nava-Ocampo AA, Kim TJ, Shim JU, Park CT.
    Reprod Toxicol; 2005 Dec; 19(4):557-61. PubMed ID: 15749271
    [Abstract] [Full Text] [Related]

  • 11. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, Olson TA, Rogers PC, Colombani P, Rescorla F, Billmire DF, Vinocur CD, Hawkins EP, Davis MM, Perlman EJ, London WB, Castleberry RP, Pediatric Oncology Group 9049, Children's Cancer Group 8882.
    J Clin Oncol; 2004 Jul 01; 22(13):2691-700. PubMed ID: 15226336
    [Abstract] [Full Text] [Related]

  • 12. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M, Miyake H, Hara I, Muramaki M, Takenaka A, Fujisawa M.
    Hinyokika Kiyo; 2007 Dec 01; 53(12):851-6. PubMed ID: 18203521
    [Abstract] [Full Text] [Related]

  • 13. A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary.
    Culine S, Kattan J, Lhomme C, Duvillard P, Michel G, Castaigne D, Leclere J, Pico J, Droz JP.
    Gynecol Oncol; 1994 Jul 01; 54(1):47-53. PubMed ID: 7517380
    [Abstract] [Full Text] [Related]

  • 14. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Group study.
    Homesley HD, Bundy BN, Hurteau JA, Roth LM.
    Gynecol Oncol; 1999 Feb 01; 72(2):131-7. PubMed ID: 10021290
    [Abstract] [Full Text] [Related]

  • 15. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.
    Gershenson DM, Morris M, Burke TW, Levenback C, Matthews CM, Wharton JT.
    Obstet Gynecol; 1996 Apr 01; 87(4):527-31. PubMed ID: 8602303
    [Abstract] [Full Text] [Related]

  • 16. Primary endodermal sinus tumor of the omentum.
    Park NH, Ryu SY, Park IA, Kang SB, Lee HP.
    Gynecol Oncol; 1999 Mar 01; 72(3):427-30. PubMed ID: 10053119
    [Abstract] [Full Text] [Related]

  • 17. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
    Low JJ, Perrin LC, Crandon AJ, Hacker NF.
    Cancer; 2000 Jul 15; 89(2):391-8. PubMed ID: 10918171
    [Abstract] [Full Text] [Related]

  • 18. Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy.
    Yoo SC, Kim WY, Yoon JH, Chang SJ, Chang KH, Ryu HS.
    Acta Obstet Gynecol Scand; 2010 Jul 15; 89(1):126-30. PubMed ID: 19878051
    [Abstract] [Full Text] [Related]

  • 19. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
    Culine S, Theodore C, Terrier-Lacombe MJ, Droz JP.
    J Urol; 1997 Mar 15; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
    [Abstract] [Full Text] [Related]

  • 20. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F, Hasanzadeh M, Karimi Zarchi M, Fallahi A.
    Int J Surg; 2008 Oct 15; 6(5):382-6. PubMed ID: 18715834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.